Total Numbers of Undiagnosed Carriers of Hepatitis C and B Viruses in Japan Estimated by Age- and Area-Specific Prevalence on the National Scale

被引:124
作者
Tanaka, Junko [1 ]
Koyama, Tomiko [3 ]
Mizui, Masaaki [2 ]
Uchida, Shigeru [5 ]
Katayama, Keiko [1 ]
Matsuo, Junko [1 ]
Akita, Tomoyuki [1 ]
Nakashima, Ayumu [1 ]
Miyakawa, Yuzo [4 ]
Yoshizawa, Hiroshi
机构
[1] Hiroshima Univ, Dept Epidemiol Infect Dis Control & Prevent, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348551, Japan
[2] Japanese Red Cross Hiroshima Blood Ctr, Hiroshima, Japan
[3] Hlth Serv Assoc, Morioka, Iwate, Japan
[4] Miyakawa Mem Res Fdn, Tokyo, Japan
[5] Japanese Red Cross Soc, Blood Serv Headquarters, Tokyo, Japan
关键词
Hepatitis C virus; Hepatitis B virus; Blood donors; Liver cirrhosis; Hepatocellular carcinoma; Healthcare; Japan; BLOOD-DONORS; WINDOW PERIOD; HBV INFECTION; UNITED-STATES; PEGINTERFERON; TRANSFUSION; TELAPREVIR; RIBAVIRIN; STRATEGY; FUTURE;
D O I
10.1159/000324525
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objective: To estimate total numbers of undiagnosed carriers of hepatitis C virus (HCV) and hepatitis B virus (HBV) in Japan. Methods: Area- and age-specific prevalence of HCV as well as HBV was determined in the first-time blood donors [20-39 years (n = 2,429,364)] and examinees of periodical health check-ups [40-74 years (6,204,968 for HCV and 6,228,967 for HBV)] in Japan. Prevalence in adolescents [5-19 years (79,256 for HCV and 68,792 for HBV)] was determined in a single prefecture, and that of HCV in the elderly (6 75 years) was estimated by the exponential model. HBV infection was determined by the detection of hepatitis B surface antigen, and HCV infection by either the algorithm or assuming persistent infection in 70% of the individuals with antibody to HCV. Results: Of the total population of 127,285,653 in 2005, 807,903 (95% CI 679,886-974,292) were estimated to be infected with HCV at a carrier rate of 0.63%, and 903,145 (837,189-969,572) with HBV at that of 0.71%. Conclusion: Accurate estimation of undiagnosed HCV and HBV carriers in the general population would help to predict the future burden of liver disease, and take appropriate measures for improving healthcare. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:185 / 195
页数:11
相关论文
共 19 条
  • [1] [Anonymous], INT KILM C P
  • [2] The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
    Armstrong, Gregory L.
    Wasley, Annemarie
    Simard, Edgar P.
    McQuillan, Geraldine M.
    Kuhnert, Wendi L.
    Alter, Miriam J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 144 (10) : 705 - 714
  • [3] Comparative sensitivity of HBVNATs and HBsAg assays for detection of acute HBV infection
    Biswas, R
    Tabor, E
    Hsia, CC
    Wright, DJ
    Laycock, ME
    Fiebig, EW
    Peddada, L
    Smith, R
    Schreiber, GB
    Epstein, JS
    Nemo, GJ
    Busch, MP
    [J]. TRANSFUSION, 2003, 43 (06) : 788 - 798
  • [4] Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection
    Busch, MP
    Glynn, SA
    Wright, DJ
    Hirschkorn, D
    Laycock, ME
    McAuley, J
    Tu, YL
    Giachetti, C
    Gallarda, J
    Heitman, J
    Kleinman, SH
    [J]. TRANSFUSION, 2005, 45 (12) : 1853 - 1863
  • [5] A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors
    Busch, MP
    Glynn, SA
    Stramer, SL
    Strong, DM
    Caglioti, S
    Wright, DJ
    Pappalardo, B
    Kleinman, SH
    [J]. TRANSFUSION, 2005, 45 (02) : 254 - 264
  • [6] Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
    Hezode, Christophe
    Forestier, Nicole
    Dusheiko, Geoffrey
    Ferenci, Peter
    Pol, Stanislas
    Goeser, Tobias
    Bronowicki, Jean-Pierre
    Bourliere, Marc
    Gharakhanian, Shahin
    Bengtsson, Leif
    McNair, Lindsay
    George, Shelley
    Kieffer, Tara
    Kwong, Ann
    Kauffman, Robert S.
    Alam, John
    Pawlotsky, Jean-Michel
    Zeuzem, Stefan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) : 1839 - 1850
  • [7] Assessing the impact of HBV NAT on window period reduction and residual risk
    Kleinman, Steven H.
    Busch, Michael P.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S23 - S29
  • [8] Perspective: Chronic hepatitis B
    Lok, ASF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22) : 1682 - 1683
  • [9] Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
    McHutchison, John G.
    Everson, Gregory T.
    Gordon, Stuart C.
    Jacobson, Ira M.
    Sulkowski, Mark
    Kauffman, Robert
    McNair, Lindsay
    Alam, John
    Muir, Andrew J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) : 1827 - 1838
  • [10] Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years
    Mizui, Masaaki
    Tanaka, Junko
    Katayama, Keiko
    Nakanishi, Toshio
    Obayashi, Makoto
    Aimitsu, Shiomi
    Yoshida, Tomoo
    Inoue, Junichi
    Yokoyama, Tatsuji
    Tsuji, Keiji
    Arataki, Keiko
    Yamaguchi, Syuji
    Miura, Toshio
    Kitamoto, Mikiya
    Takezaki, Eiichi
    Orimen, Shigeo
    Sakata, Tatsurou
    Kamada, Kouji
    Maruhashi, Akira
    Tamura, Tooru
    Nakamura, Toshio
    Ishida, Kunio
    Teramen, Kazushi
    Miyakawa, Yuzo
    Yoshizawa, Hiroshi
    [J]. HEPATOLOGY RESEARCH, 2007, 37 (12) : 994 - 1001